Cangene other research news

The Toronto company announced that it has developed a version of EPO linked to polyethylene glycol, which increases the life of the kidney hormone in circulation.

The PEG-EPO was co-developed with the Royal Free Hospital School of Medicine in London by coupling the hormone directly to PEG without an intervening molecule. ...